Tinzaparin for the prevention of thromboembolic events in ambulatory patients with metastatic colorectal cancer receiving first line treatment: a randomised, clinical trial design.
Saved in:
| Title: | Tinzaparin for the prevention of thromboembolic events in ambulatory patients with metastatic colorectal cancer receiving first line treatment: a randomised, clinical trial design. |
|---|---|
| Authors: | Salgado M; Medical Oncology Department, Complexo Hospitalario de Ourense, Ourense, Spain., de la Camara-Gómez J; Medical Oncology Department, Complexo Hospitalario Universitario, A Coruña, Spain., García-Escobar I; Medical Oncology Department, Hospital General Universitario de Toledo, Toledo, Spain., Álvarez-Llosa RC; Medical Oncology Department, Complexo Hospitalario de Ourense, Ourense, Spain., González-Villarroel P; Alvaro Cunqueiro Hospital, Vigo, Spain., Garay DF; Hospital Costa del Sol, Marbella, Spain., Pàmpols-Felip M; Medical Oncology Department, Hospital Arnau de Vilanova, Lleida, Spain., Guillot-Morales M; Medical Oncology Department, Hospital Universitario Son Espases, Palma de Mallorca, Spain., Pelegrín-Mateo FJ; Hospital General Universitario Dr. Balmis, Alicante, Spain., Jimenez-Orozco E; Hospital Universitario Jerez de la Frontera, Cádiz, Spain., Sastre J; Hospital Clinico San Carlos, Madrid, Spain., de Castro EM; Medical Oncology Department, University Hospital Marqués de Valdecilla, IDIVAL, Santander, Spain., Coma E; Institut Català d'Oncologia L'Hospitalet, Hospitalet De Llobregat , Barcelona, Spain., Bouzas LP; Centro Oncológico de Galicia, A Coruña, Spain., Ferrer-Pérez AI; Hospital Obispo Polanco, Teruel, Spain., Mompradé-Olivé E; Institut Catala D'Oncologia - Hospital Universitari Germans Trias i Pujol, Badalona, Spain., Cousillas-Castiñeiras A; Complexo Hospitalario de Pontevedra, Pontevedra, Spain., Covela-Rúa M; Hospital Universitario Lucus Augusti (HULA), Lugo, Spain., Rojas M; Hospital Clínic de Barcelona, Barcelona, Spain., Querol R; Medical Oncology Service, Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcelona Sabadell, Barcelona, Spain., Díaz LR; Medical Oncology Department, Hospital Universitario 12 de Octubre, Instituto de Investigación i+12, Madrid, Spain., Merino M; Medical Affairs Department, LEO Pharma, Barcelona, Spain., Gil M; Medical Oncology Department, General University Hospital, Valencia, Spain., Sánchez-Cánovas M; Hospital General Universitario Morales Meseguer, Murcia, Spain., Elías T; Instituto de Biomedicina (IBIS), Hospital Universitario Virgen del Rocío, Sevilla, Spain., Marrupe-González D; Hospital Universitario de Móstoles, Madrid, Spain., Sánchez-Gil B; Hospital General La Mancha Centro, Ciudad Real, Spain., Carmona-Campos M; Hospital Clínico Universitario de Santiago CHUS, Coruña, Spain., García-Ferrón M; Hospital Infanta Cristina de Parla, Madrid, Spain., Soria JM; Genomics of Complex Diseases Unit, Biomedical Research Institute Sant Pau (IIB-Sant Pau) Barcelona, Barcelona, Spain., Muñoz A; Medical Oncology Department, Hospital Universitario Gregorio Marañón, Madrid, Spain. andresmunmar@hotmail.com.; Universidad Complutense, Madrid, Spain. andresmunmar@hotmail.com. |
| Source: | BMC cancer [BMC Cancer] 2025 Nov 17; Vol. 25 (1), pp. 1773. Date of Electronic Publication: 2025 Nov 17. |
| Publication Type: | Journal Article; Clinical Trial Protocol |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1471-2407 |
|---|---|
| DOI: | 10.1186/s12885-025-14620-z |
